Pedro N. Mata

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 118 publications

European and Canadian derived risk prediction equations for atherosclerotic cardiovascular disease are valid in Australian patients with genetically confirmed familial hypercholesterolaemia.

European and Canadian derived risk prediction equations for atherosclerotic cardiovascular disease are valid in Australian patients with genetically confirmed familial hypercholesterolaemia.

Journal: Atherosclerosis

Published: February 09, 2026

Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registry.

Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registry.

Journal: European journal of preventive cardiology

Published: October 30, 2025

Lipoprotein-Specific Fatty Acid Profiles in Familial Hypercholesterolemia: Associations with Cardiovascular History and Dietary Patterns.

Lipoprotein-Specific Fatty Acid Profiles in Familial Hypercholesterolemia: Associations with Cardiovascular History and Dietary Patterns.

Journal: Nutrients

Published: October 30, 2025

Cholesterol-lowering therapy from childhood/adolescence and long-term outcomes in familial hypercholesterolaemia: the SAFEHEART study.

Cholesterol-lowering therapy from childhood/adolescence and long-term outcomes in familial hypercholesterolaemia: the SAFEHEART study.

Journal: European heart journal

Published: October 23, 2025

Risk factors for atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-analysis.

Risk factors for atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-analysis.

Journal: Atherosclerosis

Published: September 08, 2025

A miRNA signature linked to high lipoprotein (a) and coronary calcification in familial hypercholesterolaemia.

A miRNA signature linked to high lipoprotein (a) and coronary calcification in familial hypercholesterolaemia.

Journal: Computational and structural biotechnology journal

Published: May 29, 2025

External validation of the SAFEHEART risk-equation for predicting cardiovascular events in Australian patients with familial hypercholesterolaemia.

External validation of the SAFEHEART risk-equation for predicting cardiovascular events in Australian patients with familial hypercholesterolaemia.

Journal: European journal of preventive cardiology

Published: May 19, 2025

Clinical profile of familial hypercholesterolemia phenotype in adults attended in primary care in a large healthcare area.

Clinical profile of familial hypercholesterolemia phenotype in adults attended in primary care in a large healthcare area.

Journal: Atherosclerosis

Published: January 16, 2025

Implementation strategies for improving the care of familial hypercholesterolaemia from the International Atherosclerosis Society: next steps in implementation science and practice.

Implementation strategies for improving the care of familial hypercholesterolaemia from the International Atherosclerosis Society: next steps in implementation science and practice.

Journal: American journal of preventive cardiology

Published: September 20, 2024

Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?

Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?

Journal: Current opinion in endocrinology, diabetes, and obesity

Published: July 05, 2024

Total Cholesterol Determination Accuracy in Dried Blood Spots.

Total Cholesterol Determination Accuracy in Dried Blood Spots.

Journal: Diagnostics (Basel, Switzerland)

Published: July 03, 2024

Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study.

Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study.

Journal: The lancet. Diabetes & endocrinology

Published: May 22, 2024

Showing 1-12 of 118

Last Updated: 09/26/2026